title: Actual benefit of chemo-hormonal therapy in non-castrate metastatic prostate cancer.
authors.affiliation: Yıldırım Beyazıt University, Faculty of Medicine, Department of Medical Oncology, 06800 Bilkent, Ankara, Turkey.
authors.forename: Mehmet A N
authors.initials: MA
authors.lastname: Şendur
authors.forename: Muhammed Bülent
authors.initials: MB
authors.lastname: Akıncı
authors.forename: Nuriye Yıldırım
authors.initials: NY
authors.lastname: Ozdemir
authors.forename: Sercan
authors.initials: S
authors.lastname: Aksoy
authors.forename: Didem S
authors.initials: DS
authors.lastname: Dede
authors.forename: Arife
authors.initials: A
authors.lastname: Ulas
authors.forename: Nurullah
authors.initials: N
authors.lastname: Zengin
authors.forename: Bülent
authors.initials: B
authors.lastname: Yalçın
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary; D017326:Clinical Trials, Phase III as Topic; D000077143:Docetaxel; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016032:Randomized Controlled Trials as Topic; D043823:Taxoids / Q000008:administration & dosage
chemical_list: D043823:Taxoids; D000077143:Docetaxel; D007987:Gonadotropin-Releasing Hormone
keywords: androgen-deprivation treatment; castration-resistant; chemo-hormonal treatment; docetaxel; hormone sensitive; prostate cancer